Literature DB >> 9514097

Heterogeneous suppression of experimentally induced colon cancer metastasis in rat liver lobes by inhibition of extracellular cathepsin B.

C J Van Noorden1, T G Jonges, J Van Marle, E R Bissell, P Griffini, M Jans, J Snel, R E Smith.   

Abstract

Metastatic rat colon cancer cells but not normal rat hepatocytes showed activity of cathepsin B on their plasma membranes. Activity was visualized in living cells with a new fluorogenic substrate, [Z-Arg]2-cresyl violet, and confocal microscopy. When these cancer cells were injected into the portal vein of rats, the animals developed tumors in the liver in a heterogeneous fashion. Three- to four-fold more tumors were found in the small caudate lobe than in the other three large lobes of the liver. Oral treatment with a selective water-soluble inhibitor of extracellular cathepsin B, Mu-Phe-homoPhe-fluoromethylketone, resulted in 60% reduction of the number of tumors and 80% reduction of the volume of tumors in the three large lobes whereas tumor development was not affected in the small caudate lobe. This study supports the conclusions that (a) extracellular cathepsin B plays a crucial but complex role in liver colonisation by rat colon carcinoma cells in vivo, (b) its selective inhibition suppresses tumor growth heterogeneously in the liver and (c) the caudate lobe of the liver is a relatively large risk factor for tumor development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514097     DOI: 10.1023/a:1006524321335

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  78 in total

1.  Ala-Pro-cresyl violet, a synthetic fluorogenic substrate for the analysis of kinetic parameters of dipeptidyl peptidase IV (CD26) in individual living rat hepatocytes.

Authors:  C J Van Noorden; E Boonacker; E R Bissell; A J Meijer; J van Marle; R E Smith
Journal:  Anal Biochem       Date:  1997-10-01       Impact factor: 3.365

Review 2.  Pit cells in the liver.

Authors:  L Bouwens; E Wisse
Journal:  Liver       Date:  1992-02

3.  Fibronectin: a discrimination marker between small invasive carcinomas and benign proliferative lesions of the breast.

Authors:  L Christensen
Journal:  APMIS       Date:  1990-07       Impact factor: 3.205

Review 4.  Secretion of cathepsin B and tumour invasion.

Authors:  D Keppler; M Abrahamson; B Sordat
Journal:  Biochem Soc Trans       Date:  1994-02       Impact factor: 5.407

5.  Antibodies to plasminogen activator inhibit human tumor metastasis.

Authors:  L Ossowski; E Reich
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

6.  Phenotypic characterization of metaplastic intestinal glands and ductular hepatocytes in cholangiofibrotic lesions rapidly induced in the caudate liver lobe of rats treated with furan.

Authors:  L W Elmore; A E Sirica
Journal:  Cancer Res       Date:  1991-10-15       Impact factor: 12.701

7.  Cathepsin B activity in human lung tumor cell lines: ultrastructural localization, pH sensitivity, and inhibitor status at the cellular level.

Authors:  E Spiess; A Brüning; S Gack; B Ulbricht; H Spring; G Trefz; W Ebert
Journal:  J Histochem Cytochem       Date:  1994-07       Impact factor: 2.479

8.  3-Methyladenine, an inhibitor of autophagy, has multiple effects on metabolism.

Authors:  L H Caro; P J Plomp; E J Wolvetang; C Kerkhof; A J Meijer
Journal:  Eur J Biochem       Date:  1988-08-01

9.  Inhibition of the cathepsin B like proteinase by a low molecular weight cysteine-proteinase inhibitor from ascitic fluid and plasma alpha 2 macroglobulin.

Authors:  M Pagano; D Keppler; V Fumeron-Dalet; R Engler
Journal:  Biochem Cell Biol       Date:  1986-12       Impact factor: 3.626

10.  Interferon treatment of a transplantable rat colon adenocarcinoma: importance of tumor site.

Authors:  R L Marquet; D L Westbroek; J Jeekel
Journal:  Int J Cancer       Date:  1984-05-15       Impact factor: 7.396

View more
  17 in total

1.  In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma metastasis.

Authors:  S M Smorenburg; R Vink; M te Lintelo; W Tigchelaar; A Maas; H R Büller; C J van Noorden
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Tenascin immunoreactivity in the large bowel and the liver in patients with colorectal cancer.

Authors:  M V Gulubova; T Vlaykova
Journal:  Histochem J       Date:  2001-02

3.  Cathepsin B mediates TRAIL-induced apoptosis in oral cancer cells.

Authors:  Nagathihalli S Nagaraj; Nadarajah Vigneswaran; Wolfgang Zacharias
Journal:  J Cancer Res Clin Oncol       Date:  2005-12-16       Impact factor: 4.553

Review 4.  Imaging enzymes at work: metabolic mapping by enzyme histochemistry.

Authors:  Cornelis J F Van Noorden
Journal:  J Histochem Cytochem       Date:  2010-02-01       Impact factor: 2.479

5.  Reduction of proteinuria through podocyte alkalinization.

Authors:  Mehmet M Altintas; Kumiko Moriwaki; Changli Wei; Clemens C Möller; Jan Flesche; Jing Li; Suma Yaddanapudi; Mohd Hafeez Faridi; Markus Gödel; Tobias B Huber; Richard A Preston; Jean X Jiang; Dontscho Kerjaschki; Sanja Sever; Jochen Reiser
Journal:  J Biol Chem       Date:  2014-05-09       Impact factor: 5.157

6.  Optical imaging with a novel cathepsin-activatable probe for enhanced detection of colorectal cancer.

Authors:  Shadi A Esfahani; Pedram Heidari; Melanie H Kucherlapati; Jorge M Ferrer; Raju S Kucherlapati; Umar Mahmood
Journal:  Am J Nucl Med Mol Imaging       Date:  2019-10-15

7.  Promotion of colon cancer metastases in rat liver by fish oil diet is not due to reduced stroma formation.

Authors:  L Klieveri; O Fehres; P Griffini; C J Van Noorden; W M Frederiks
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 8.  Is there a genetic signature for liver metastasis in colorectal cancer?

Authors:  Cristina Nadal; Joan Maurel; Pere Gascon
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

9.  Structural examination of tryptase- and chymase-positive mast cells in livers, containing metastases from gastrointestinal cancers.

Authors:  Maya Vladova Gulubova
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

10.  The metastatic potential of human pancreatic cell lines in the liver of nude mice correlates well with cathepsin B activity.

Authors:  George N Tzanakakis; Andrew N Margioris; Aristidis M Tsatsakis; Michael P Vezeridis
Journal:  Int J Gastrointest Cancer       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.